Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-20 · accession 0001661539-23-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-22 | 2023-12-20 | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $20.00 | -2,252 | 2,251 | -50% | -$45.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | S | D | 2,252 | $20.00 | 2,251 | D | — | — |